Nate Crossett

Stock Analyst at Exane BNP Paribas

(2.36)
# 2,482
Out of 4,735 analysts
37
Total ratings
48%
Success rate
0.22%
Average return

Stocks Rated by Nate Crossett

Medical Properties Trust
Jul 2, 2024
Downgrades: Neutral
Price Target: $6$4
Current: $4.09
Upside: -2.20%
Omega Healthcare Investors
Feb 8, 2024
Upgrades: Neutral
Price Target: $30
Current: $37.36
Upside: -19.70%
Agree Realty
Dec 13, 2023
Downgrades: Neutral
Price Target: $64
Current: $72.44
Upside: -11.65%
NETSTREIT
Dec 13, 2023
Downgrades: Neutral
Price Target: $17
Current: $14.57
Upside: +16.68%
Realty Income
Dec 13, 2023
Upgrades: Outperform
Price Target: $63
Current: $54.62
Upside: +15.34%
Alexandria Real Estate Equities
Oct 11, 2023
Initiates: Neutral
Price Target: $108
Current: $101.79
Upside: +6.10%
Ventas
Oct 11, 2023
Initiates: Outperform
Price Target: n/a
Current: $58.90
Upside: -
Digital Realty Trust
Jul 28, 2023
Upgrades: Outperform
Price Target: $138
Current: $178.43
Upside: -22.66%
Prologis
Jul 20, 2023
Upgrades: Outperform
Price Target: $141
Current: $109.48
Upside: +28.79%
Gaming and Leisure Properties
Jun 14, 2023
Initiates: Outperform
Price Target: $63
Current: $48.05
Upside: +31.11%
Initiates: Underperform
Price Target: $42
Current: $40.07
Upside: +4.82%
Initiates: Outperform
Price Target: $41
Current: $29.35
Upside: +39.69%
Initiates: Outperform
Price Target: $29
Current: $31.70
Upside: -8.52%
Initiates: Underperform
Price Target: $74
Current: $55.79
Upside: +32.64%
Initiates: Outperform
Price Target: n/a
Current: $17.00
Upside: -
Initiates: Underperform
Price Target: $9.6
Current: $7.22
Upside: +32.96%
Initiates: Outperform
Price Target: $66
Current: $109.22
Upside: -39.57%
Initiates: Outperform
Price Target: $38
Current: $21.40
Upside: +77.57%
Initiates: Outperform
Price Target: $886
Current: $915.59
Upside: -3.23%
Downgrades: Hold
Price Target: $31$30
Current: $27.56
Upside: +8.85%
Initiates: Buy
Price Target: $21
Current: $4.62
Upside: +354.55%
Downgrades: Hold
Price Target: $21$25
Current: $10.77
Upside: +132.13%
Upgrades: Buy
Price Target: n/a
Current: $23.52
Upside: -